China Pharmaceutical Chain Industry Report, 2009
  • Oct/2009
  • Hard Copy
  • USD $1,600
  • Pages:80
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: ZHM005
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,500
  • Hard Copy + Single User License
  • USD $1,800
      

According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 billion (30.35%) than RMB43.91 billion in 2007. 

Sales Revenue of Top 100 Enterprises in China Pharmaceutical Chain Industry, 2003-2008
 2009101603.gif
 Source: ResearchInChina 

In 2008, the average profit margin of top 100 enterprises was 3.76%, more 0.76 points than that in 2007

Profit Margin of Top 100 Enterprises in China Pharmaceutical Chain Industry, 2008
 2009101604.gif
Source: ResearchInChina

The data of this report come from China Association of Pharmaceutical Commerce, www.pharmnet.com.cn, www.ydzz.com and the National Bureau of Statistics of China. The report makes an in-depth analysis of the operation and future development of pharmaceutical chain industry, guiding investment and financing decision-making.

This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry. Chapter 1 introduces the development of China pharmaceutical chain industry briefly. Chapter 2 analyzes the macroeconomic environment, industry environment and policies related with China pharmaceutical chain industry. Chapter 3, 4, 5 analyze operation, competition patterns and key areas of China pharmaceutical chain industry, such as market scale, profitability, competition patterns and regional difference. Chapter 6 analyzes the development trends of China pharmaceutical chain industry. Finally, Chapter 7 analyzes the development, revenue distribution and profitability of over 10 key Chinese pharmaceutical enterprises, including LBX Pharmacy, Nepstar, Hubei Tongjitang, Chongqing Tongjunge Pharmacy, Sinopharm Group Co., Ltd., Chongqing Peace Drugstore.

1 Overview of China Pharmaceutical Chain Industry  
1.1 Rapid Development 
1.2 Models of Chain Operation 
1.1.1 Regular Chain
1.1.2 Franchise 
1.1.3 Comparison 
1.3 Problems

2 Environment for China Pharmaceutical Chain Industry    
2.1 Macro-economy 
2.2 Industry 
2.3 Policy 
2.3.1 Challenges Brought by New Medical Reform in the Short Term
2.3.2 Opportunities Brought by New Medical Reform in the Long Run
2.3.3 New Medical Reform is Expected to Promote "the Separation of Hospitals and Medicine

3 Operation of China Pharmaceutical Chain Industry
3.1 Key Indicators 
3.1.1 Market Scale
3.1.2 Profit 
3.1.3 Efficiency 
3.1.4 Other Indicators 
3.2 Consumption Structure 
3.3 Trend of Drug Prices 
3.4 Industry Expansion 
3.5 Operation Formats

4 Competition in China Pharmaceutical Chain Industry
4.1 Market Concentration 
4.2 Competition Pattern 
4.3 Comparison of Major Enterprises
4.3.1 Overall Scale 
4.3.2 Economic Benefits

5 Key Areas of China Pharmaceutical Chain Industry
5.1 Beijing 
5.2 Shanghai 
5.3 Guangdong 
5.4 Jiangsu 
5.5 Hunan 
5.6 Liaoning
5.7 Others

6 Development Trends of China Pharmaceutical Chain Industry
6.1 Market Trends 
6.2 Consumption Structure 
6.3 Drug Prices 
6.4 Competition 
6.5 Operation of Pharmacies  
6.5.1 Drugstores in Marketing Era 
6.5.2 Transformation of Traditional Pharmacies 
6.5.3 Alliances of Small and Medium Pharmacies 
6.5.4 Return of Direct Chains 
6.5.5 Capital will become the Primary Means for Industry Consolidation 
6.6 Key Fields  
6.6.1 OTC Drug Market 
6.6.2 Medicare Drugs 
6.6.3 Cosmeceutical Stores

7 Key Enterprises in China Pharmaceutical Chain Industry
7.1 LBX Pharmacy
7.1.1 Profile
7.1.2 Revenue
7.1.3 Distribution of Chain Drugstores
7.2 Nepstar
7.2.1 Profile
7.2.2 Revenue
7.2.3 Distribution of Chain Drugstores
7.3 Hubei Tongjitang
7.3.1 Profile
7.3.2 Revenue
7.3.3 Distribution of Chain Drugstores
7.4 Chongqing Tongjunge Pharmacy
7.4.1 Profile
7.4.2 Revenue
7.4.3 Distribution of Chain Drugstores
7.5 Sinopharm Group Co., Ltd.
7.5.1 Profile
7.5.2 Revenue
7.5.3 Distribution of Chain Drugstores
7.6 Liaoning CDFY
7.6.1 Profile
7.6.2 Revenue
7.6.3 Distribution of Chain Drugstores
7.7 Chongqing Peace Drugstore
7.7.1 Profile
7.7.2 Revenue
7.7.3 Distribution of Chain Drugstores
7.8 Guangdong Da Shen Lin
7.8.1 Profile
7.8.2 Revenue
7.8.3 Distribution of Chain Drugstores
7.9 Yunnan Hongxiang Yixintang
7.9.1 Profile
7.9.2 Revenue
7.9.3 Distribution of Chain Drugstores
7.10 Beijing Jinxiang Pharmacy
7.10.1 Profile
7.10.2 Revenue
7.10.3 Distribution of Chain Drugstores
7.11 Tong Ren Tang
7.12 Guizhou 1-Tree
7.13 Medicine Shoppe
Sales Revenue of Top 100 Enterprises in China Pharmaceutical Chain Industry in Recent Years
Comparison between Franchise and Direct Marketing 
GDP and Its Growth Rate in China, 2002-2008
Positive Correlation between GDP and Sales Revenue of China Pharmaceutical Chain Industry
Market Scale of Pharmaceutical Manufacturing, Jan-May 2009 
Sales Growth Rate of China Pharmaceutical Industry, 1990-Feb 2009 
Profit Growth Rate of China Pharmaceutical Industry, 1990- Feb 2009 
Overall Framework of Health Care Reform
Forecast for Sales Revenue and Growth Rate of China Pharmaceutical Chain Industry, 2008-2010
Sales Revenue of Top 100 Enterprises in China Pharmaceutical Chain Industry, 2003-2008
Top 10 Enterprises in China Pharmaceutical Chain Industry by Sales Revenue, 2008
Profit Margin of Top 100 Enterprises in China Pharmaceutical Chain Industry, 2008
Top 10 Enterprises in China Pharmaceutical Chain Industry by Profit Margin, 2008
Area Efficiency of Top 100 Enterprises (by Sales Revenue) in China Pharmaceutical Chain Industry, 2008 
Top 10 Enterprises in China Pharmaceutical Chain Industry by Area Efficiency, 2008 
Salesperson Efficiency of Top 100 Enterprises (by Sales Revenue) in China Pharmaceutical Chain Industry, 2008 
Top 10 Enterprises in China Pharmaceutical Chain Industry by Salesperson Efficiency, 2008
Average indicators of Top 100 Enterprises (by Sales Revenue) in China Pharmaceutical Chain Industry, 2007-2008 
Drug Structure of Retail Pharmaceutical Market by Sales Revenue, Q1-Q3 2008 
Retail Prices of Drugs in China, 2003-Aug 2009
Total Number of Drugstores of Top 100 Enterprises (by Sales Revenue) in China Pharmaceutical Chain Industry, 2004-2008
Top 10 Chinese Pharmaceutical Chain Enterprises by Number of Drugstores, 2008 
Operation Formats of Chinese Pharmaceutical Chain Enterprises
Market Concentration of China Pharmaceutical Chain Industry, 2006-2008
Pharmaceutical Chain Enterprises That have been Top 20 in Successive 5 Years by Sales Revenue
Top 10 Enterprises in China Pharmaceutical Chain Industry by Growth Rate, 2008 
Sales Revenue Ranking in China Pharmaceutical Chain Industry, 2008
Top 20 Chinese Chain Drugstores by Number of Franchises, 2008 
Sales Revenue Ranking in China Pharmaceutical Chain Industry by Single Drugstore, 2008 
Profit Comparison between State-owned and Private enterprises in China Pharmaceutical Chain Industry, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Beijing, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Shanghai, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Guangdong, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Jiangsu, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Hunan, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Liaoning, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Hubei, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Yunan, 2008 
Sales Revenue of Major Pharmaceutical Chain Enterprises in Chongqing, 2008 
Terminal Pharmaceutical Market Reforms
Forecast for Sales Revenue of China Retail Pharmaceutical Market, 2008-2010 
Shares of Drugs in Retail Pharmaceutical Market by Sales Revenue, 2007-2008
Drug Structure of Retail Pharmaceutical Market by Sales Revenue, 2007-2008
Top 10 Best-sold Cold Medicines in Retail Pharmaceutical Market, 2008
Revenue of LBX Pharmacy, 2003-2008
Geographical Distribution of LBX Pharmacy’s Drugstores, 2008 
Revenue of Nepstar, 2003-2008
Number and Expansion Rate of Nepstar’s Drugstores, 2003-2008 
Revenue of Hubei Tongjitang, 2003-2008
Expansion Rate of Hubei Tongjitang’s Drugstores, 2003-2008
Revenue of Chongqing Tongjunge Pharmacy, 2003-2008 
Expansion Rate of Chongqing Tongjunge Pharmacy’s Drugstores, 2003-2008 
Revenue of Sinopharm Group Co., Ltd., 2003-2008 
Expansion Rate of Sinopharm Group Co., Ltd’s Drugstores, 2003-2008
Revenue of Liaoning CDFY, 2003-2008 
Number and Expansion Rate of Nepstar’s Drugstores, 2002-2008
Revenue of Chongqing Peace Drugstore, 2003-2008 
Expansion Rate of Chongqing Peace Drugstore’s Drugstores, 2003-2008
Revenue of Guangdong Da Shen Lin, 2003-2008 
Expansion Rate of Guangdong Da Shen Lin, 2003-2008 
Revenue of Yunnan Hongxiang Yixintang, 2003-2008 
Distribution of Yunnan Hongxiang Yixintang’s Drugstores, by the End of Jun 2009 
Revenue of Beijing Jinxiang Pharmacy, 2003-2008 
Expansion Rate of Beijing Jinxiang Pharmacy’s Drugstores, 2004-2008
Geographical Distribution of Medicine Shoppe’s Drugstores in China 

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统